Born 1971, licensed physician, Med. Dr. John has broad knowledge and experience in drug development across several therapeutic areas, including CNS, cancer and blood disorders. He has held leading clinical research roles at AstraZeneca, Shire Pharmaceuticals and Medivir. Before joining Karolinska Development, he was Chief Medical Officer at Modus Therapeutics. John held various research and clinical positions at Lund University and the Karolinska Institute/University Hospital before he began working in drug development.

No holdings in KDventures.